[HTML][HTML] Current aspects in sepsis approach. Turning things around

…, JT Ramos, J Rello, B Suberviola… - Revista Española de …, 2018 - ncbi.nlm.nih.gov
The incidence and prevalence of sepsis depend on the definitions and records that we use
and we may be underestimating their impact. Up to 60% of the cases come from the …

Impact of the Surviving Sepsis Campaign protocols on hospital length of stay and mortality in septic shock patients: results of a three-year follow-up quasi …

Á Castellanos-Ortega, B Suberviola… - Critical care …, 2010 - journals.lww.com
Objectives: To describe the effectiveness of the Surviving Sepsis Campaign bundles with
regard to both implementation and outcome in patients with septic shock and to determine the …

[HTML][HTML] Improving the outcomes of organs obtained from controlled donation after circulatory death donors using abdominal normothermic regional perfusion

E Miñambres, B Suberviola, B Dominguez-Gil… - American Journal of …, 2017 - Elsevier
The use of donation after circulatory death (DCD) has increased significantly during the past
decade. However, warm ischemia results in a greater risk for transplantation. Indeed, …

Pharmacological treatment of COVID-19: narrative review of the Working Group in Infectious Diseases and Sepsis (GTEIS) and the Working Groups in Transfusions …

…, PV Cortés, MG Escapa, B Suberviola… - Medicina Intensiva …, 2021 - Elsevier
Infection by the SARS-CoV-2 virus, known as COVID-19 (COronaVIrus Disease-19) was
initially detected in China in December 2019, and has subsequently spread rapidly throughout …

Hospital mortality prognostication in sepsis using the new biomarkers suPAR and proADM in a single determination on ICU admission

B Suberviola, A Castellanos-Ortega, A Ruiz Ruiz… - Intensive care …, 2013 - Springer
Purpose The soluble form of the urokinase-type plasminogen activator receptor (suPAR) and
proadrenomedullin (proADM) are two new and promising sepsis biomarkers. We assessed …

Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza A

…, F García-López, B Suberviola… - Journal of …, 2011 - academic.oup.com
Objectives The impact of oseltamivir on mortality in critically ill patients with 2009 pandemic
influenza A (2009 H1N1) is not clear. The main objective of this study was to investigate the …

Procalcitonin (PCT) levels for ruling-out bacterial coinfection in ICU patients with influenza: a CHAID decision-tree analysis

…, R Zaragoza, J Bonastre, JE Guerrero, B Suberviola… - Journal of infection, 2016 - Elsevier
Objectives To define which variables upon ICU admission could be related to the presence
of coinfection using CHAID (Chi-squared Automatic Interaction Detection) analysis. Methods …

Prognostic value of procalcitonin, C-reactive protein and leukocytes in septic shock

B Suberviola, A Castellanos-Ortega… - Medicina Intensiva …, 2012 - Elsevier
Objectives This study evaluates the potential prognostic value of serial measurements of
different biomarkers (procalcitonin [PCT], C-reactive protein and leukocytes [CRP]) in septic …

Early complications of high-dose methylprednisolone in acute spinal cord injury patients

B Suberviola, A González-Castro, J Llorca… - Injury, 2008 - Elsevier
BACKGROUND: To evaluate the early complications and effect on neurological outcome of
methylprednisolone (MP) treatment in spinal cord injury (SCI) patients during the acute phase…

Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia

B Suberviola, A Castellanos-Ortega, J Llorca… - Swiss Medical …, 2012 - smw.ch
PRINCIPLES: Midregional proadrenomedullin (proADM) is a novel biomarker with potential
prognostic utility in patients with community-acquired pneumonia. The aim of this study was …